Safety and Impact of Anti-COVID-19 Vaccines in Psoriatic Patients Treated with Biologics: A Real Life Experience
Since all clinical trials conducted during the development of anti-COVID-19 vaccines have adopted among the exclusion criteria the presence of immunodepression or immunomodulating therapy, to date, the effects of vaccination against the new coronavirus 2 in people under such conditions have yet to b...
Main Authors: | Nevena Skroza, Nicoletta Bernardini, Ersilia Tolino, Ilaria Proietti, Alessandra Mambrin, Anna Marchesiello, Federica Marraffa, Giovanni Rossi, Salvatore Volpe, Concetta Potenza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/15/3355 |
Similar Items
-
Management of psoriatic patients in biologic treatment associated with infectious comorbidities
by: Bernardini Nicoletta, et al.
Published: (2020-07-01) -
Long-Term Maintained Response to Selective Internal Radiation Therapy in an Oligometastatic Uveal Melanoma Patient Treated with Concomitant Anti-PD-1 Therapy
by: Ilaria Proietti, et al.
Published: (2021-07-01) -
How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy
by: N. Bernardini, et al.
Published: (2021-07-01) -
A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma
by: Concetta Potenza, et al.
Published: (2018-01-01) -
Do Diet and Lifestyles Play a Role in the Pathogenesis of NMSCs?
by: Nevena Skroza, et al.
Published: (2020-11-01)